tradingkey.logo

Cencora Inc

COR

289.150USD

-1.550-0.53%
終値 08/12, 16:00ET15分遅れの株価
56.05B時価総額
33.10直近12ヶ月PER

Cencora Inc

289.150

-1.550-0.53%
詳細情報 Cencora Inc 企業名
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
企業情報
企業コードCOR
会社名Cencora Inc
上場日May 28, 1996
最高経営責任者「CEO」Dr. Robert P. (Bob) Mauch, Ph.D.
従業員数42000
証券種類Ordinary Share
決算期末May 28
本社所在地1 West First Avenue
都市CONSHOHOCKEN
証券取引所NYSE Consolidated
United States of America
郵便番号19428
電話番号16107277000
ウェブサイトhttps://www.cencora.com/
企業コードCOR
上場日May 28, 1996
最高経営責任者「CEO」Dr. Robert P. (Bob) Mauch, Ph.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
309.91K
-0.64%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
19.11K
-13.57%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
14.71K
+0.31%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.53K
+0.98%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
11.35K
-26.17%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.02K
+4.35%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
957.00
+469.64%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
516.00
--
Ms. Lauren M. Tyler
Ms. Lauren M. Tyler
Independent Director
Independent Director
--
--
Mr. Bennett S. Murphy
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
309.91K
-0.64%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
19.11K
-13.57%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
14.71K
+0.31%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.53K
+0.98%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
11.35K
-26.17%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.02K
+4.35%
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: 2 hours ago
更新時刻: 2 hours ago
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.55%
BlackRock Institutional Trust Company, N.A.
6.21%
Walgreens Boots Alliance Inc
4.96%
T. Rowe Price Associates, Inc.
4.81%
State Street Global Advisors (US)
4.34%
Other
68.13%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.55%
BlackRock Institutional Trust Company, N.A.
6.21%
Walgreens Boots Alliance Inc
4.96%
T. Rowe Price Associates, Inc.
4.81%
State Street Global Advisors (US)
4.34%
Other
68.13%
種類
株主統計
比率
Investment Advisor
50.49%
Investment Advisor/Hedge Fund
29.79%
Corporation
4.96%
Hedge Fund
3.74%
Research Firm
3.47%
Pension Fund
2.35%
Bank and Trust
2.23%
Family Office
1.17%
Family Office
1.17%
Other
0.64%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
2306
191.45M
98.75%
-197.41K
2025Q1
2293
192.45M
99.29%
-2.90M
2024Q4
2214
199.54M
103.03%
-6.12M
2024Q3
2134
200.05M
102.56%
+474.02K
2024Q2
2090
200.10M
100.34%
-7.14M
2024Q1
2068
201.37M
100.95%
-1.37M
2023Q4
1982
202.46M
101.40%
+179.01K
2023Q3
1885
197.70M
97.79%
-2.16M
2023Q2
1870
195.01M
96.41%
-1.88M
2023Q1
1823
192.70M
95.24%
-7.51M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
21.28M
10.98%
+51.74K
+0.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
11.01M
5.68%
+234.21K
+2.17%
Mar 31, 2025
Walgreens Boots Alliance Inc
9.62M
4.96%
-765.00K
-7.37%
Jun 09, 2025
T. Rowe Price Associates, Inc.
9.33M
4.81%
+724.11K
+8.41%
Mar 31, 2025
State Street Global Advisors (US)
8.41M
4.34%
+382.24K
+4.76%
Mar 31, 2025
Wellington Management Company, LLP
5.42M
2.8%
+363.40K
+7.18%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.50M
2.32%
+177.32K
+4.10%
Mar 31, 2025
Boston Partners
5.41M
2.79%
+404.09K
+8.07%
Mar 31, 2025
Capital Research Global Investors
2.91M
1.5%
+8.07K
+0.28%
Mar 31, 2025
JP Morgan Asset Management
2.87M
1.48%
-576.23K
-16.70%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Wed, Aug 6
更新時刻: Wed, Aug 6
銘柄名
比率
AdvisorShares Focused Equity ETF
4.92%
First Trust Consumer Staples Alphadex Fund
3.82%
Invesco Dorsey Wright Healthcare Momentum ETF
3.38%
VanEck Retail ETF
3.19%
VanEck Pharmaceutical ETF
2.87%
American Century Mid Cap Growth Impact ETF
2.55%
First Trust Dorsey Wright Momentum & Low Vol ETF
2.51%
Counterpoint Quantitative Equity ETF
2.36%
SEI Enhanced US Large Cap Momentum Factor ETF
2.33%
iShares US Consumer Staples ETF
2.3%
詳細を見る
AdvisorShares Focused Equity ETF
比率4.92%
First Trust Consumer Staples Alphadex Fund
比率3.82%
Invesco Dorsey Wright Healthcare Momentum ETF
比率3.38%
VanEck Retail ETF
比率3.19%
VanEck Pharmaceutical ETF
比率2.87%
American Century Mid Cap Growth Impact ETF
比率2.55%
First Trust Dorsey Wright Momentum & Low Vol ETF
比率2.51%
Counterpoint Quantitative Equity ETF
比率2.36%
SEI Enhanced US Large Cap Momentum Factor ETF
比率2.33%
iShares US Consumer Staples ETF
比率2.3%
配当金
過去5年間の配当金総支払額は 1.92B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
Aug 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
Aug 11, 2023
Aug 28, 2023
Aug 10, 2023
May 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023
May 12, 2023
May 30, 2023
May 11, 2023
Feb 01, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023
Feb 10, 2023
Feb 27, 2023
Feb 09, 2023
Nov 04, 2022
COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI